Inventor · disambiguated record
Kevin John Kauffman
Also filed as: KAUFFMAN KEVIN · KAUFFMAN KEVIN J · KAUFFMAN KEVIN JOHN
10 granted patents·3 pending applications·55 citations·filing 2016–2023
86Inventor score
Top patents by PatentIndex Score
13 records- 0196US10201618B2Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Feb 12, 2019·37 cites·26 claims
- 0294US10695444B2Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Jun 30, 2020·11 cites·22 claims
- 0388US11696953B2Poly(beta-amino esters) and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Granted Jul 11, 2023·1 cites·23 claims
- 0486US12415776B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Sep 16, 2025·0 cites·28 claims
- 0586US12384741B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Aug 12, 2025·0 cites·28 claims
- 0686US12180138B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·0 cites·28 claims
- 0786US12077485B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Sep 3, 2024·0 cites·28 claims
- 0884US11679165B2Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Jun 20, 2023·1 cites·37 claims
- 0982US11608412B2Polymer-lipids and compositionsMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Mar 21, 2023·3 cites·34 claims
- 1082US11464860B2Poly (beta-amino esters) and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Oct 11, 2022·2 cites·5 claims
- 1179US2023338577A1Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Application pending·0 cites
- 1262US2025268828A1Lipid Nanoparticle Compositions for Delivering Circular PolynucleotidesORNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1344US2021317461A1Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereofVERSEAU THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin John Kauffman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →